Nextgen Healthcare Inc (NXGN) Receives $18.50 Consensus PT from Analysts

Shares of Nextgen Healthcare Inc (NASDAQ:NXGN) have earned a consensus recommendation of “Hold” from the six research firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $18.50.

Several equities research analysts have recently issued reports on NXGN shares. Dougherty & Co upgraded shares of Nextgen Healthcare from a “neutral” rating to a “buy” rating and set a $19.00 price objective on the stock in a research note on Friday, January 11th. Zacks Investment Research upgraded shares of Nextgen Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, January 7th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $23.00 price objective on shares of Nextgen Healthcare in a research note on Thursday, December 6th.

Several institutional investors have recently made changes to their positions in the company. PNC Financial Services Group Inc. grew its stake in shares of Nextgen Healthcare by 37.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,387 shares of the company’s stock worth $36,000 after acquiring an additional 649 shares during the last quarter. Comerica Bank grew its stake in shares of Nextgen Healthcare by 1.4% in the fourth quarter. Comerica Bank now owns 47,000 shares of the company’s stock worth $813,000 after acquiring an additional 665 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in shares of Nextgen Healthcare by 2.2% in the fourth quarter. Thrivent Financial for Lutherans now owns 33,809 shares of the company’s stock worth $512,000 after acquiring an additional 743 shares during the last quarter. O Shaughnessy Asset Management LLC grew its stake in shares of Nextgen Healthcare by 3.2% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 43,381 shares of the company’s stock worth $658,000 after acquiring an additional 1,356 shares during the last quarter. Finally, Texas Permanent School Fund grew its stake in shares of Nextgen Healthcare by 4.7% in the fourth quarter. Texas Permanent School Fund now owns 31,315 shares of the company’s stock worth $474,000 after acquiring an additional 1,415 shares during the last quarter. Institutional investors and hedge funds own 71.64% of the company’s stock.

NASDAQ:NXGN opened at $16.83 on Wednesday. Nextgen Healthcare has a 12 month low of $13.17 and a 12 month high of $23.73. The company has a market capitalization of $1.09 billion, a PE ratio of 30.60, a PEG ratio of 3.31 and a beta of 1.16. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.31 and a current ratio of 1.32.

Nextgen Healthcare (NASDAQ:NXGN) last released its quarterly earnings results on Wednesday, January 23rd. The company reported $0.12 EPS for the quarter, beating the Zacks’ consensus estimate of $0.11 by $0.01. Nextgen Healthcare had a net margin of 1.80% and a return on equity of 10.66%. The company had revenue of $130.87 million for the quarter, compared to analyst estimates of $130.79 million. Analysts predict that Nextgen Healthcare will post 0.57 earnings per share for the current fiscal year.

About Nextgen Healthcare

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Recommended Story: Why Invest in Dividend Achievers?

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.